Evaluating the Commercial Potential of Narrative Care Interventions in Alleviating Anxiety, Depression, and Enhancing Quality of Life in Women with High-Risk HPV Infections

Abstract

This study examines the therapeutic potential of narrative nursing—a biopsychosocial intervention—on the psychological well-being and quality of life in women diagnosed with high-risk human papillomavirus (HR-HPV). Given the pronounced psychological impacts associated with HR-HPV, particularly among women of childbearing age, this research implements a personalized narrative nursing intervention to address these challenges. The study involved 160 confirmed cases of HR-HPV, where the effectiveness of narrative nursing was assessed through rigorous statistical analysis. Results indicate a significant improvement in quality of life scores for the intervention group compared to controls (P<0.05), with narrative nursing also receiving high commendation from both patients and their families, suggesting its efficacy in reducing healthcare disputes. Psychologically, the intervention markedly alleviated symptoms such as depression, anxiety, and somatization, with factor loadings all exceeding 0.6, demonstrating strong correlations between psychological distress and HR-HPV prevalence. The findings propose that narrative nursing not only enhances patient outcomes but also presents a viable commercial application in biotechnological healthcare innovations, potentially guiding future strategies for managing psychological conditions associated with chronic diseases.